Bispecific Antibody Drug Conjugate

Zurich, Switzerland, July 27, 2026 VERAXA Biotech AG announced the advancement of its VXA-222 bispecific antibody-drug conjugate (bsADC) program...

BOTHELL, Wash., July 8, 2026 Immunome, Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted...

BOSTON and MORRISTOWN, N.J., July 7, 2026 Biocytogen and Whitehawk Therapeutics have announced a global strategic collaboration to accelerate...